DAWN Latest Press Releases

-- November 24, 2025 --

Day One Announces Three Year Follow-Up Data From OJEMDA (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting Globe Newswire 8:00 AM

-- November 18, 2025 --

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference Globe Newswire 8:30 AM

-- November 13, 2025 --

Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases Globe Newswire 6:00 AM

-- November 10, 2025 --

Day One Announces New OJEMDA (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting Globe Newswire 7:00 AM

-- November 4, 2025 --

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress Globe Newswire 4:00 PM

-- October 21, 2025 --

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025 Globe Newswire 8:30 AM

-- August 5, 2025 --

Day One Reports Second Quarter 2025 Financial Results and Corporate Progress Globe Newswire 4:00 PM

-- July 22, 2025 --

Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025 Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software